Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-14

Clinical Trial Update: Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing multiple-dose versus single-dose ivermectin for the treatment of strongyloidiasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVERMECTIN (Ivermectin)

Snippet

Sponsor: Centro per le Malattie Tropicali | Conditions: Strongyloidiasis | Phase 3 | Status: COMPLETED